Oct 25, 2024, 19:14
Next-Generation HER2-Targeted ADC’s in Breast Cancer – Cancers MDPI
Cancers MDPI shared a post on LinkedIn:
”Check out the Editor’s Choice Article ‘Next-Generation HER2-Targeted Antibody–Drug Conjugates in Breast Cancer‘ by Brittney Shulman Zimmerman and Francisco J. Esteva.
I believe that this article would be worth highlighting as it addresses one of the newest and most exciting areas of cancer therapeutics.”
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 26, 2024, 18:39
Oct 26, 2024, 18:30
Oct 26, 2024, 18:28
Oct 26, 2024, 18:16
Oct 26, 2024, 18:03